Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Dr Parag Sheth, Regional Director-Regulatory & Medical at Abbott, said original is produced via recombinant DNA biotechnology, while many upcoming products use synthetic peptide processes that differ significantly
Cells 13 (5), 439
A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users
Published in the Journal of Clinical Investigation Insight , the research found that inconsistent use of GLP-1 drugs may reduce their effectiveness when patients resume treatment
US$ 27.90
US$ 22.03
US$ 26.95
US$ 22.23
US$ 24.36
US$ 29.59
US$ 25.69
